JP2011026335A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011026335A5 JP2011026335A5 JP2010223566A JP2010223566A JP2011026335A5 JP 2011026335 A5 JP2011026335 A5 JP 2011026335A5 JP 2010223566 A JP2010223566 A JP 2010223566A JP 2010223566 A JP2010223566 A JP 2010223566A JP 2011026335 A5 JP2011026335 A5 JP 2011026335A5
- Authority
- JP
- Japan
- Prior art keywords
- tablet
- progesterone
- vaginal administration
- administration according
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims 25
- 229960003387 progesterone Drugs 0.000 claims 11
- 239000000186 progesterone Substances 0.000 claims 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims 4
- 239000004088 foaming agent Substances 0.000 claims 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 4
- 229960001207 micronized progesterone Drugs 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims 2
- 229920002472 Starch Polymers 0.000 claims 2
- 241000209149 Zea Species 0.000 claims 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims 2
- 235000011037 adipic acid Nutrition 0.000 claims 2
- 239000001361 adipic acid Substances 0.000 claims 2
- 235000005822 corn Nutrition 0.000 claims 2
- 238000009434 installation Methods 0.000 claims 2
- 239000008101 lactose Substances 0.000 claims 2
- 235000019359 magnesium stearate Nutrition 0.000 claims 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 2
- 229940069328 povidone Drugs 0.000 claims 2
- 239000000377 silicon dioxide Substances 0.000 claims 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims 2
- 239000008107 starch Substances 0.000 claims 2
- 235000019698 starch Nutrition 0.000 claims 2
- 210000001215 vagina Anatomy 0.000 claims 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 1
- 208000034423 Delivery Diseases 0.000 claims 1
- 238000007907 direct compression Methods 0.000 claims 1
- 238000001599 direct drying Methods 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 230000009677 vaginal delivery Effects 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL12712998A IL127129A (en) | 1998-11-18 | 1998-11-18 | Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000582018A Division JP4667601B2 (ja) | 1998-11-18 | 1999-11-17 | プロゲステロン含有経膣投与用錠剤およびその調製法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011026335A JP2011026335A (ja) | 2011-02-10 |
| JP2011026335A5 true JP2011026335A5 (enExample) | 2012-01-26 |
Family
ID=11072154
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000582018A Expired - Lifetime JP4667601B2 (ja) | 1998-11-18 | 1999-11-17 | プロゲステロン含有経膣投与用錠剤およびその調製法 |
| JP2010223566A Pending JP2011026335A (ja) | 1998-11-18 | 2010-10-01 | プロゲステロン含有経膣投与用錠剤およびその調製法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000582018A Expired - Lifetime JP4667601B2 (ja) | 1998-11-18 | 1999-11-17 | プロゲステロン含有経膣投与用錠剤およびその調製法 |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US7300664B1 (enExample) |
| EP (2) | EP2386291A1 (enExample) |
| JP (2) | JP4667601B2 (enExample) |
| AU (1) | AU1176200A (enExample) |
| DK (1) | DK1131052T3 (enExample) |
| ES (1) | ES2390959T3 (enExample) |
| IL (1) | IL127129A (enExample) |
| WO (1) | WO2000028970A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL127129A (en) * | 1998-11-18 | 2004-06-01 | Ferring Bv | Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared |
| FR2821555B1 (fr) * | 2001-03-01 | 2003-05-16 | Besins Int Lab | Progestatif co-micronise avec un tensioactif, composition pharmaceutique le comprenant, leurs procedes de fabrication et leurs utilisations |
| KR20050084445A (ko) * | 2002-12-20 | 2005-08-26 | 다이노젠 파마세우티컬스, 인코포레이티드 | α₂δ 서브유닛 칼슘 채널 모듈레이터를 이용한 무통증방광 질환의 치료방법 |
| ES2275229T3 (es) * | 2003-03-21 | 2007-06-01 | Dynogen Pharmaceuticals, Inc. | Metodos para el tratamiento de desordenes del tracto urinario iferior utilizando antimuscarinos y moduladores de la subunidad alfa-2-delta del canal de calcio. |
| DE10316583A1 (de) * | 2003-04-10 | 2004-10-28 | B.R.A.H.M.S Aktiengesellschaft | Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung |
| US8828981B2 (en) | 2007-02-06 | 2014-09-09 | George Creasy | Progesterone for the treatment or prevention of spontaneous preterm birth |
| CA2744906A1 (en) * | 2007-11-29 | 2009-06-04 | Gregg A. Jackson | Progesterone-containing compositions and devices |
| US9107696B2 (en) | 2008-08-06 | 2015-08-18 | Emory University | Method of embryo transfer that eliminates transferred air while hormonally inducing implantation and apparatus |
| WO2011073995A2 (en) | 2009-12-14 | 2011-06-23 | Lincoln Pharmaceuticals Limited | Liquid vaginal spray of progesterone |
| FR2997627B1 (fr) * | 2012-11-08 | 2015-01-16 | Hra Pharma Lab | Produit de co-micronisation comprenant de l'ulipristal acetate |
| CN114129530A (zh) * | 2021-12-08 | 2022-03-04 | 南京康川济医药科技有限公司 | 一种黄体酮缓释组合物及其制备方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3121663A (en) | 1956-02-09 | 1964-02-18 | Plough Lab Inc | Carbon dioxide releasing laxative suppository |
| US4252787A (en) * | 1976-12-27 | 1981-02-24 | Cambridge Research And Development Group | Anti-fertility composition and method |
| US4310510A (en) * | 1976-12-27 | 1982-01-12 | Sherman Kenneth N | Self administrable anti-fertility composition |
| US4187286A (en) * | 1979-01-02 | 1980-02-05 | G&W Laboratories, Inc. | Contraceptive suppository |
| US4322399A (en) * | 1979-10-19 | 1982-03-30 | Ortho Pharmaceutical Corporation | Vaginal suppository |
| JPS58152809A (ja) * | 1982-03-05 | 1983-09-10 | Eisai Co Ltd | 安定な発泡性「膣」坐剤 |
| US4583211A (en) * | 1982-06-15 | 1986-04-15 | Tokyo Shibaura Denki Kabushiki Kaisha | Frequency detecting circuit for digital information reproducing system |
| JPS6165822A (ja) * | 1984-09-06 | 1986-04-04 | Kao Corp | 月経困難症治療用膣投与剤 |
| US5116619A (en) * | 1988-08-30 | 1992-05-26 | Lee Roy Morgan | Vaginal progesterone tablet |
| US5084277A (en) * | 1988-08-30 | 1992-01-28 | Greco John C | Vaginal progesterone tablet |
| DK95093D0 (da) * | 1993-08-20 | 1993-08-20 | Novo Nordisk As | Farmaceutisk formulering indeholdende et hormon |
| US5543150A (en) * | 1993-09-15 | 1996-08-06 | Columbia Laboratories, Inc. | Method of progesterone delivery and affect thereof |
| CH689802A5 (de) * | 1995-01-16 | 1999-11-30 | Grapha Holding Ag | Einrichtung zur Vereinzelung von stapelweise zugeführten flachen Gegenständen. |
| US5804277A (en) * | 1995-11-30 | 1998-09-08 | The United States Of America As Represented By The Secretary Of The Air Force | Three-dimensional fiber weave with cubic symmetry and no zero valued shear moduli |
| US5958455A (en) * | 1996-02-09 | 1999-09-28 | Quadrant Holdings Cambridge Ltd | Oral solid dosage forms, methods of making same and compositions thereof |
| US5837861A (en) * | 1997-02-10 | 1998-11-17 | Inspire Pharmaceuticals, Inc. | Dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency |
| US6096291A (en) * | 1996-12-27 | 2000-08-01 | Biovector Therapeutics, S.A. | Mucosal administration of substances to mammals |
| US5993856A (en) | 1997-01-24 | 1999-11-30 | Femmepharma | Pharmaceutical preparations and methods for their administration |
| US6306914B1 (en) * | 1997-10-21 | 2001-10-23 | Columbia Laboratories, Inc. | Progestin therapy for maintaining amenorrhea |
| NZ330596A (en) * | 1998-06-05 | 2001-02-23 | Dec Res | Intravaginal devices allowing for increased uptake of active ingredients |
| FR2772617B1 (fr) | 1997-12-19 | 2001-03-09 | Besins Iscovesco Lab | Comprime de progesterone et son procede de preparation |
| FR2777784B1 (fr) * | 1998-04-27 | 2004-03-19 | Arepa | Composition pharmaceutique a base d'estrogene et de progesterone |
| IL127129A (en) * | 1998-11-18 | 2004-06-01 | Ferring Bv | Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared |
| US20070178139A1 (en) * | 1998-11-18 | 2007-08-02 | Yankov Vladimir I | Vaginally administratable progesterone-containing tablets and method for preparing same |
| DE102012021570A1 (de) * | 2012-11-02 | 2014-05-22 | Merck Patent Gmbh | Eu-aktivierte Leuchtstoffe |
-
1998
- 1998-11-18 IL IL12712998A patent/IL127129A/en not_active IP Right Cessation
-
1999
- 1999-11-17 WO PCT/IL1999/000619 patent/WO2000028970A1/en not_active Ceased
- 1999-11-17 JP JP2000582018A patent/JP4667601B2/ja not_active Expired - Lifetime
- 1999-11-17 EP EP11166346A patent/EP2386291A1/en not_active Ceased
- 1999-11-17 US US09/856,417 patent/US7300664B1/en not_active Expired - Lifetime
- 1999-11-17 DK DK99972096.4T patent/DK1131052T3/da active
- 1999-11-17 EP EP99972096A patent/EP1131052B1/en not_active Expired - Lifetime
- 1999-11-17 ES ES99972096T patent/ES2390959T3/es not_active Expired - Lifetime
- 1999-11-17 AU AU11762/00A patent/AU1176200A/en not_active Abandoned
-
2004
- 2004-04-26 US US10/832,742 patent/US7393543B2/en not_active Expired - Lifetime
-
2005
- 2005-01-12 US US11/039,062 patent/US7320800B2/en not_active Expired - Lifetime
-
2006
- 2006-04-20 US US11/408,614 patent/US20060188571A1/en not_active Abandoned
-
2010
- 2010-10-01 JP JP2010223566A patent/JP2011026335A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011026335A5 (enExample) | ||
| JP2010047612A5 (enExample) | ||
| CA2842175C (en) | Tablet containing dehydroepiandrosterone (dhea) | |
| CN101703513B (zh) | 阿司匹林和氯吡格雷或其药学上可接受的盐的复方缓释制剂 | |
| NZ599594A (en) | Fast dissolving solid dosage form | |
| JP2011037832A5 (enExample) | ||
| JP2013501717A5 (enExample) | ||
| HRP20161262T1 (hr) | Tablete ulipristal acetata | |
| JP2016540021A5 (enExample) | ||
| JP2013529665A5 (enExample) | ||
| CN103550165A (zh) | 一种含有利伐沙班的药物组合物及其制备方法 | |
| CN103751139A (zh) | 鲁拉西酮口腔崩解片 | |
| CN103340837B (zh) | 一种米索前列醇阴道泡腾片及其制备方法 | |
| CN106163518B (zh) | 包含血管紧张素-Ⅱ受体阻断剂和HMG-CoA还原酶抑制剂的药物组合制剂 | |
| JP2014037356A (ja) | カンデサルタンシレキセチル経口製剤 | |
| CN101862325B (zh) | 一种含有坎地沙坦酯的药物组合物 | |
| CN102727455A (zh) | 一种他达那非口腔崩解片及其制备方法 | |
| WO2011063775A3 (en) | Pectin complexes of sartans and pharmaceutical compositions based thereon | |
| RU2011108370A (ru) | Жевательная композиция, включающая альгинат, бикарбонат и карбонат | |
| CN101167723B (zh) | 缬沙坦分散片及其制备方法 | |
| WO2009008004A3 (en) | Sustained release formulations of divalproex sodium | |
| JP4871258B2 (ja) | トラセミドとマトリックス形成ポリマーとを含む持続放出型組成物（ｐｒｏｌｏｎｇｅｄ−ｒｅｌｅａｓｅ ｃｏｍｐｏｓｉｔｉｏｎ） | |
| CN103800334A (zh) | 甲磺酸伊马替尼的药物组合物及其制备方法 | |
| CN102552170A (zh) | 一种以苯磺酸普拉格雷为活性成分的固体制剂 | |
| JP2013543881A5 (enExample) |